Cervical Cancer Screening Guidelines
Women should begin cervical cancer screening at age 21 regardless of sexual history, with screening every 3 years using cytology (Pap test) alone for ages 21-29, and preferably every 5 years with HPV and cytology co-testing (or every 3 years with cytology alone) for ages 30-65. 1
Age to Begin Screening
- Start screening at age 21 regardless of sexual debut or sexual history
- Screening is not recommended for women under 21 years of age, as cervical cancer is extremely rare in this age group 1, 2
- This represents a significant change from earlier guidelines that recommended starting screening at a younger age or with onset of sexual activity 1
Screening Intervals by Age Group
Ages 21-29:
- Cervical cytology (Pap test) alone every 3 years
- HPV testing is not recommended for this age group 1
Ages 30-65:
- Preferred approach: HPV and cytology co-testing every 5 years
- Acceptable alternative: Cytology alone every 3 years 1, 3
- Annual screening is not recommended by current guidelines 2
When to Discontinue Screening
Women can discontinue cervical cancer screening at age 65 if they meet ALL of the following criteria:
- Have had at least 3 consecutive negative Pap tests or at least 2 consecutive negative HPV and Pap tests within the last 10 years
- Most recent test occurred within the last 5 years
- No history of cervical cancer or high-grade precancerous lesions 1
Women who have had a total hysterectomy (with removal of the cervix) for benign reasons and have no history of high-grade precancerous lesions should discontinue screening 1.
Special Populations Requiring Different Screening Protocols
- Women with HIV infection: Pap test twice in the first year after diagnosis, then annually if results are normal
- Women with immunocompromised status, in utero DES exposure, or previous cervical cancer/high-grade precancerous lesions: Require more intensive screening protocols
- Women who have had a subtotal hysterectomy (cervix remains): Continue age-appropriate screening
- Women with history of cervical cancer, high-grade precancerous lesions, in utero DES exposure, or immunocompromised status: Continue screening beyond age 65 1
Common Pitfalls to Avoid
Screening too early: Starting screening before age 21 can lead to unnecessary interventions for transient HPV infections that would likely resolve on their own 1, 2
Screening too frequently: Annual screening is no longer recommended for any age group and can lead to overtreatment and increased costs 1, 2
Discontinuing screening prematurely: Never discontinue screening before age 65 in average-risk women without verifying adequate prior screening 1
Failing to screen women aged 22-30: Despite the trend toward following guidelines for not screening women under 21, there has been a concerning increase in the proportion of women aged 22-30 who report never having had a Pap test (from 6.6% to 9.0%) 2
Continuing screening unnecessarily: Women who have had a total hysterectomy for benign reasons with no history of high-grade precancerous lesions do not need continued screening 1
The evolution of these guidelines reflects the understanding that cervical cancer is rare in young women and that too-frequent screening can lead to unnecessary procedures and potential harm from overtreatment. Following these evidence-based recommendations optimizes the benefits of screening while minimizing potential harms.